Black Rock Inc. Oramed Pharmaceuticals Inc. Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Oramed Pharmaceuticals Inc. stock. As of the latest transaction made, Black Rock Inc. holds 89,295 shares of ORMP stock, worth $228,595. This represents 0.0% of its overall portfolio holdings.

Number of Shares

89,295

Previous 87,758 1.75%

Holding current value

$228,595

Previous $202,000 28.71%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$2.18 - $3.58 $3,350 - $5,502	1,537 Added 1.75%	89,295 $260,000
Q4 2023 Feb 13, 2024	SELL	$1.71 - $2.57 $1,778 - $2,672	-1,040 Reduced 1.17%	87,758 $202,000
Q3 2023 Nov 13, 2023	SELL	$2.51 - $3.55 $23,172 - $32,773	-9,232 Reduced 9.42%	88,798 $231,000
Q2 2023 Aug 11, 2023	BUY	$2.12 - $4.47 $17,721 - $37,364	8,359 Added 9.32%	98,030 $350,000
Q1 2023 May 12, 2023	SELL	$1.93 - $13.1 $31,321 - $212,599	-16,229 Reduced 15.32%	89,671 $195,000

Q4 2022 Feb 13, 2023	BUY	$6.21 - $12.03 $22,983 - $44,523	3,701 Added 3.62%	105,900 $1.27 Million
Q3 2022 Nov 14, 2022	SELL	$4.6 - $9.91 $169,523 - $365,213	-36,853 Reduced 26.5%	102,199 $662,000
Q2 2022 Aug 12, 2022	SELL	$3.72 - $9.0 $6.29 Million - $15.2 Million	-1,691,114 Reduced 92.4%	139,052 $637,000
Q1 2022 May 12, 2022	BUY	$8.19 - $13.89 $2.22 Million - $3.77 Million	271,559 Added 17.42%	1,830,166 $15.8 Million
Q4 2021 Feb 10, 2022	BUY	$12.98 - $29.75 $1.62 Million - $3.72 Million	125,059 Added 8.72%	1,558,607 $22.3 Million
Q3 2021 Nov 09, 2021	BUY	$12.13 - $23.82 $1.99 Million - $3.91 Million	164,018 Added 12.92%	1,433,548 $31.5 Million
Q2 2021 Aug 11, 2021	BUY	$8.34 - $14.59 $10.6 Million - $18.5 Million	1,269,530 New	1,269,530 $17 Million

Others Institutions Holding ORMP

# of Institutions

Shares Held

5.69M

Call Options Held

8.3K

Put Options Held

2.7K

View Full List

About ORAMED PHARMACEUTICALS INC.

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $99.4M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

More about ORMP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account